Farallon Capital Management »

Medline shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 260k 42.00

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding Medline

Carlyle
H&F Corporate Investors X
Vanguard Group
Capital Research Global Investors
BlackRock
Baillie Gifford & Co
Massachusetts Financial Services
WCM Investment Management
T. Rowe Price Investment Management
Viking Global Investors
Durable Capital Partners
Norges Bank Investment Management
Artisan Partners Limited Partnership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors

View all funds holding Medline